Vaccinex, Inc.
VCNX
$0.72
-$0.02-2.70%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 41.14% | -1.79% | -44.50% | -17.49% | 32.47% |
| Total Depreciation and Amortization | -29.17% | -7.69% | -3.70% | 0.00% | -12.90% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -94.33% | 3,286.49% | 103.33% | 42.64% | -1,782.61% |
| Change in Net Operating Assets | -151.76% | 8.24% | 231.32% | 113.85% | -250.33% |
| Cash from Operations | -22.61% | 27.36% | 4.68% | 40.13% | -149.98% |
| Capital Expenditure | 100.00% | 42.86% | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 100.00% | 42.86% | -- | -- | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 43.75% | -357.14% | 63.16% | -11.76% | 10.53% |
| Issuance of Common Stock | -- | -- | -100.00% | 4.28% | 253.15% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -100.00% | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -200.00% | -- | -100.00% | -74.65% | -- |
| Cash from Financing | -63.77% | 248.40% | -72.15% | -33.64% | 586.56% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -167.30% | 197.59% | -290.61% | 2.06% | 179.06% |